The World Congress/DSS-II: Two seminal events in one!! This will be an unprecedented gathering to review the latest research in metabolic surgery and to develop new guidelines for the development of a modern, multi-modality approach to the care of type 2 diabetes.
The 3rd World Congress on Interventional Therapies for Type 2 Diabetes is a comprehensive, multidisciplinary forum where leading international experts will conduct a critical review and discussion of the latest research findings on metabolic/bariatric surgery and novel interventional therapies for type 2 diabetes.
The first 2 editions where held in New York City in 2008 and 2011 with the participation of world leading experts, including Nobel laureates, and with attendees from over 60 countries.
The signature design of this congress includes state-of-the art invited lectures and debates among clinicians, scientists, and policy makers. The congress also welcomes submission of original abstracts on subjects such as clinical outcomes, mechanisms of action and cost-effectiveness of metabolic surgery, new device-based therapies of obesity and diabetes, gastrointestinal physiology and its role
in glucose metabolism.